Pregnancy and Autoimmune Thyroid Disease: Alternating Between Hypothyroidism and Hyperthyroidism And The Role of Thyrotropin-Receptor Antibodies

ABSTRACT: Objective: To report the case of a female patient with hypothyroidism who spontaneously developed Graves hyperthyroidism during pregnancy and then reverted back to hypothyroidism in a subsequent pregnancy.Methods: The pertinent clinical features, laboratory data, and clinical course of the...

Full description

Bibliographic Details
Main Authors: Sara Awad, MBBS, FRCPC, Heidi Dutton, MD, FRCPC, Julie Shaw, PhD, FCACB, Erin Keely, MD, FRCPC
Format: Article
Language:English
Published: Elsevier 2017-01-01
Series:AACE Clinical Case Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2376060520304302
id doaj-c08402b482d94b3a83e862cd71351ed3
record_format Article
spelling doaj-c08402b482d94b3a83e862cd71351ed32021-04-30T07:24:39ZengElsevierAACE Clinical Case Reports2376-06052017-01-0134340343Pregnancy and Autoimmune Thyroid Disease: Alternating Between Hypothyroidism and Hyperthyroidism And The Role of Thyrotropin-Receptor AntibodiesSara Awad, MBBS, FRCPC0Heidi Dutton, MD, FRCPC1Julie Shaw, PhD, FCACB2Erin Keely, MD, FRCPC3From the Department of Medicine, Division of Endocrinology and Metabolism, University of Ottawa, Ottawa, Ontario, Canada.; Address correspondence to Dr. Sara Awad, The Ottawa Hospital, Riverside Campus, 1967 Riverside Drive, Room 4-12, Ottawa, ON, Canada K1H 7W9From the Department of Medicine, Division of Endocrinology and Metabolism, University of Ottawa, Ottawa, Ontario, Canada.Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Ontario, Canada.From the Department of Medicine, Division of Endocrinology and Metabolism, University of Ottawa, Ottawa, Ontario, Canada.ABSTRACT: Objective: To report the case of a female patient with hypothyroidism who spontaneously developed Graves hyperthyroidism during pregnancy and then reverted back to hypothyroidism in a subsequent pregnancy.Methods: The pertinent clinical features, laboratory data, and clinical course of the case are reported, along with a brief literature review.Results: A 30-year-old female with hypothyroidism diagnosed at age 20 years unexpectedly required decreased levothyroxine dosing during her second pregnancy. She was taking levothyroxine 12.5 μg daily when she became pregnant a third time. In the first trimester, levothyroxine was discontinued, and she presented in the third trimester with clinical and biochemical hyperthyroidism and a diffusely enlarged goiter. Propylthiouracil (PTU) was initiated. Thyroid-stimulating hormone–receptor antibodies (TRAbs) were positive. After delivery, her baby developed transient neonatal Graves disease. She was continued on a stable dose of PTU for 10 months postpartum and then became pregnant a fourth time. PTU was discontinued and she remained euthyroid off medications until the second trimester, when she presented with clinical and biochemical hypothyroidism, requiring levothyroxine initiation. TRAb level was elevated. Thyroid-stimulating immunoglobulin (TSI) bioassay was elevated. Despite elevated TSI in her fourth pregnancy, her child did not develop neonatal Graves disease. She remains euthyroid on levothyroxine.Conclusion: Spontaneous transformation from hypothyroidism to hyperthyroidism during pregnancy is rare but can occur. The balance between the activity of stimulating and blocking TRAbs may impact the clinical presentation for both the mother and the fetus.Abbreviations: AITD autoimmune thyroid disease; FT3 free triiodothyronine; FT4 free thyroxine; GD Graves disease; LT4 levothyroxine; PTU propylthiouracil; TBAb thyroid-blocking antibody; TRAb thyroid-stimulating hormone–receptor antibody; TSAb thyroid-stimulating antibody; TSH thyroid-stimulating hormonehttp://www.sciencedirect.com/science/article/pii/S2376060520304302
collection DOAJ
language English
format Article
sources DOAJ
author Sara Awad, MBBS, FRCPC
Heidi Dutton, MD, FRCPC
Julie Shaw, PhD, FCACB
Erin Keely, MD, FRCPC
spellingShingle Sara Awad, MBBS, FRCPC
Heidi Dutton, MD, FRCPC
Julie Shaw, PhD, FCACB
Erin Keely, MD, FRCPC
Pregnancy and Autoimmune Thyroid Disease: Alternating Between Hypothyroidism and Hyperthyroidism And The Role of Thyrotropin-Receptor Antibodies
AACE Clinical Case Reports
author_facet Sara Awad, MBBS, FRCPC
Heidi Dutton, MD, FRCPC
Julie Shaw, PhD, FCACB
Erin Keely, MD, FRCPC
author_sort Sara Awad, MBBS, FRCPC
title Pregnancy and Autoimmune Thyroid Disease: Alternating Between Hypothyroidism and Hyperthyroidism And The Role of Thyrotropin-Receptor Antibodies
title_short Pregnancy and Autoimmune Thyroid Disease: Alternating Between Hypothyroidism and Hyperthyroidism And The Role of Thyrotropin-Receptor Antibodies
title_full Pregnancy and Autoimmune Thyroid Disease: Alternating Between Hypothyroidism and Hyperthyroidism And The Role of Thyrotropin-Receptor Antibodies
title_fullStr Pregnancy and Autoimmune Thyroid Disease: Alternating Between Hypothyroidism and Hyperthyroidism And The Role of Thyrotropin-Receptor Antibodies
title_full_unstemmed Pregnancy and Autoimmune Thyroid Disease: Alternating Between Hypothyroidism and Hyperthyroidism And The Role of Thyrotropin-Receptor Antibodies
title_sort pregnancy and autoimmune thyroid disease: alternating between hypothyroidism and hyperthyroidism and the role of thyrotropin-receptor antibodies
publisher Elsevier
series AACE Clinical Case Reports
issn 2376-0605
publishDate 2017-01-01
description ABSTRACT: Objective: To report the case of a female patient with hypothyroidism who spontaneously developed Graves hyperthyroidism during pregnancy and then reverted back to hypothyroidism in a subsequent pregnancy.Methods: The pertinent clinical features, laboratory data, and clinical course of the case are reported, along with a brief literature review.Results: A 30-year-old female with hypothyroidism diagnosed at age 20 years unexpectedly required decreased levothyroxine dosing during her second pregnancy. She was taking levothyroxine 12.5 μg daily when she became pregnant a third time. In the first trimester, levothyroxine was discontinued, and she presented in the third trimester with clinical and biochemical hyperthyroidism and a diffusely enlarged goiter. Propylthiouracil (PTU) was initiated. Thyroid-stimulating hormone–receptor antibodies (TRAbs) were positive. After delivery, her baby developed transient neonatal Graves disease. She was continued on a stable dose of PTU for 10 months postpartum and then became pregnant a fourth time. PTU was discontinued and she remained euthyroid off medications until the second trimester, when she presented with clinical and biochemical hypothyroidism, requiring levothyroxine initiation. TRAb level was elevated. Thyroid-stimulating immunoglobulin (TSI) bioassay was elevated. Despite elevated TSI in her fourth pregnancy, her child did not develop neonatal Graves disease. She remains euthyroid on levothyroxine.Conclusion: Spontaneous transformation from hypothyroidism to hyperthyroidism during pregnancy is rare but can occur. The balance between the activity of stimulating and blocking TRAbs may impact the clinical presentation for both the mother and the fetus.Abbreviations: AITD autoimmune thyroid disease; FT3 free triiodothyronine; FT4 free thyroxine; GD Graves disease; LT4 levothyroxine; PTU propylthiouracil; TBAb thyroid-blocking antibody; TRAb thyroid-stimulating hormone–receptor antibody; TSAb thyroid-stimulating antibody; TSH thyroid-stimulating hormone
url http://www.sciencedirect.com/science/article/pii/S2376060520304302
work_keys_str_mv AT saraawadmbbsfrcpc pregnancyandautoimmunethyroiddiseasealternatingbetweenhypothyroidismandhyperthyroidismandtheroleofthyrotropinreceptorantibodies
AT heididuttonmdfrcpc pregnancyandautoimmunethyroiddiseasealternatingbetweenhypothyroidismandhyperthyroidismandtheroleofthyrotropinreceptorantibodies
AT julieshawphdfcacb pregnancyandautoimmunethyroiddiseasealternatingbetweenhypothyroidismandhyperthyroidismandtheroleofthyrotropinreceptorantibodies
AT erinkeelymdfrcpc pregnancyandautoimmunethyroiddiseasealternatingbetweenhypothyroidismandhyperthyroidismandtheroleofthyrotropinreceptorantibodies
_version_ 1721498414120697856